2V
Verastem, Inc.
2VSA.F · FSX
6.91 € -1.73% (-0.12 €)
1M +15.60%
Market Cap $643.7M
P/E Ratio -
Div. Yield -
ROE 468.00%
Piotroski F-Score Moderate
4/9Valuation
6 /100
Expensive P/S 7.36x
P/B 12.88x
P/E N/A
Growth
91 /100
Growing Rev. growth 128.36%
Book val. growth 6.47%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 86.69%
FCF margin 185.24%
Net margin 231.61%
Quality
5 /100
Poor ROIC 119.33%
Asset turnover 0.42x
ROE 468.00%
Debt
36 /100
Moderate Debt/Equity 1.69x
Int. coverage -147.99x
Current ratio 2.25x
Stability
38 /100
Moderate Beta 0.29x
Profitable years 0
EPS volatility 30.48%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na 2VSA.F
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Daniel W. Paterson
Employees
102
Headquarters
Needham
Nadcházející události
03 LIS
Earnings
Upcoming earnings report